Cordis Recruits Guidant To Block Taxus, Develop Combined Delivery System
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Cordis is betting that its drug-eluting stent marketing alliance with Guidant will allow it to match Boston Scientific's sales presence in U.S. cath labs